Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats

Chu Lin Chou, Yu Hsien Lai, Teng Yi Lin, Tony J F Lee, Te Chao Fang

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Introduction: The renin-angiotensin system plays a major role in the pathogenesis of metabolic syndrome. The objective of this study was to examine the effects of aliskiren, a direct renin inhibitor, on the metabolic syndrome of fructose-fed rats. Material and methods: Male Sprague-Dawley rats were divided into 4 groups (n = 6 for each group). Group Con: rats were fed a standard chow diet for 8 weeks, group Fru: rats were fed a high fructose diet (60% fructose) for 8 weeks, group FruA: rats were fed a high fructose diet and were co-infused with aliskiren (100 mg/kg/day), and group FruB: rats were treated as group Fru, but aliskiren was administered 4 weeks later. Systolic blood pressure (SBP), homeostasis model assessment-insulin resistance (HOMA-IR), and blood profiles were measured. Results: By the end of week 4 and 8 of a high fructose diet, SBP had increased significantly from 111 ±5 to 142 ±4 and 139 ±5 mmHg (p <0.05), respectively. A high fructose diet significantly increased HOMA-IR from baseline (6.15 ±1.59) to 21.25 ±2.08 and 21.28 ±3.1 (p <0.05) at week 4 and 8, respectively, and significantly induced metabolic syndrome. Concurrent aliskiren treatment prevented the development of hypertension and metabolic syndrome in fructosefed rats. When fructose-induced hypertension was established, subsequent aliskiren treatment for 4 weeks reversed the elevated SBP and ameliorated metabolic syndrome. There were no significant differences in food, water intake, urine flow or body weight gain among groups. Conclusions: Aliskiren not only prevents but also ameliorates metabolic syndrome in fructose-fed rats.

Original languageEnglish
Pages (from-to)882-888
Number of pages7
JournalArchives of Medical Science
Volume7
Issue number5
DOIs
Publication statusPublished - 2011

Fingerprint

Fructose
Blood Pressure
Diet
Insulin Resistance
Homeostasis
Hypertension
aliskiren
Renin-Angiotensin System
Renin
Drinking
Weight Gain
Sprague Dawley Rats
Eating
Body Weight
Urine
Therapeutics

Keywords

  • Aliskiren
  • Direct renin inhibitor
  • Fructose
  • Hypertension
  • Metabolic syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats. / Chou, Chu Lin; Lai, Yu Hsien; Lin, Teng Yi; Lee, Tony J F; Fang, Te Chao.

In: Archives of Medical Science, Vol. 7, No. 5, 2011, p. 882-888.

Research output: Contribution to journalArticle

Chou, Chu Lin ; Lai, Yu Hsien ; Lin, Teng Yi ; Lee, Tony J F ; Fang, Te Chao. / Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats. In: Archives of Medical Science. 2011 ; Vol. 7, No. 5. pp. 882-888.
@article{9d257b21ce4640e19c25499b8ed1005a,
title = "Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats",
abstract = "Introduction: The renin-angiotensin system plays a major role in the pathogenesis of metabolic syndrome. The objective of this study was to examine the effects of aliskiren, a direct renin inhibitor, on the metabolic syndrome of fructose-fed rats. Material and methods: Male Sprague-Dawley rats were divided into 4 groups (n = 6 for each group). Group Con: rats were fed a standard chow diet for 8 weeks, group Fru: rats were fed a high fructose diet (60{\%} fructose) for 8 weeks, group FruA: rats were fed a high fructose diet and were co-infused with aliskiren (100 mg/kg/day), and group FruB: rats were treated as group Fru, but aliskiren was administered 4 weeks later. Systolic blood pressure (SBP), homeostasis model assessment-insulin resistance (HOMA-IR), and blood profiles were measured. Results: By the end of week 4 and 8 of a high fructose diet, SBP had increased significantly from 111 ±5 to 142 ±4 and 139 ±5 mmHg (p <0.05), respectively. A high fructose diet significantly increased HOMA-IR from baseline (6.15 ±1.59) to 21.25 ±2.08 and 21.28 ±3.1 (p <0.05) at week 4 and 8, respectively, and significantly induced metabolic syndrome. Concurrent aliskiren treatment prevented the development of hypertension and metabolic syndrome in fructosefed rats. When fructose-induced hypertension was established, subsequent aliskiren treatment for 4 weeks reversed the elevated SBP and ameliorated metabolic syndrome. There were no significant differences in food, water intake, urine flow or body weight gain among groups. Conclusions: Aliskiren not only prevents but also ameliorates metabolic syndrome in fructose-fed rats.",
keywords = "Aliskiren, Direct renin inhibitor, Fructose, Hypertension, Metabolic syndrome",
author = "Chou, {Chu Lin} and Lai, {Yu Hsien} and Lin, {Teng Yi} and Lee, {Tony J F} and Fang, {Te Chao}",
year = "2011",
doi = "10.5114/aoms.2011.25566",
language = "English",
volume = "7",
pages = "882--888",
journal = "Archives of Medical Science",
issn = "1734-1922",
publisher = "Termedia Publishing House Ltd.",
number = "5",

}

TY - JOUR

T1 - Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats

AU - Chou, Chu Lin

AU - Lai, Yu Hsien

AU - Lin, Teng Yi

AU - Lee, Tony J F

AU - Fang, Te Chao

PY - 2011

Y1 - 2011

N2 - Introduction: The renin-angiotensin system plays a major role in the pathogenesis of metabolic syndrome. The objective of this study was to examine the effects of aliskiren, a direct renin inhibitor, on the metabolic syndrome of fructose-fed rats. Material and methods: Male Sprague-Dawley rats were divided into 4 groups (n = 6 for each group). Group Con: rats were fed a standard chow diet for 8 weeks, group Fru: rats were fed a high fructose diet (60% fructose) for 8 weeks, group FruA: rats were fed a high fructose diet and were co-infused with aliskiren (100 mg/kg/day), and group FruB: rats were treated as group Fru, but aliskiren was administered 4 weeks later. Systolic blood pressure (SBP), homeostasis model assessment-insulin resistance (HOMA-IR), and blood profiles were measured. Results: By the end of week 4 and 8 of a high fructose diet, SBP had increased significantly from 111 ±5 to 142 ±4 and 139 ±5 mmHg (p <0.05), respectively. A high fructose diet significantly increased HOMA-IR from baseline (6.15 ±1.59) to 21.25 ±2.08 and 21.28 ±3.1 (p <0.05) at week 4 and 8, respectively, and significantly induced metabolic syndrome. Concurrent aliskiren treatment prevented the development of hypertension and metabolic syndrome in fructosefed rats. When fructose-induced hypertension was established, subsequent aliskiren treatment for 4 weeks reversed the elevated SBP and ameliorated metabolic syndrome. There were no significant differences in food, water intake, urine flow or body weight gain among groups. Conclusions: Aliskiren not only prevents but also ameliorates metabolic syndrome in fructose-fed rats.

AB - Introduction: The renin-angiotensin system plays a major role in the pathogenesis of metabolic syndrome. The objective of this study was to examine the effects of aliskiren, a direct renin inhibitor, on the metabolic syndrome of fructose-fed rats. Material and methods: Male Sprague-Dawley rats were divided into 4 groups (n = 6 for each group). Group Con: rats were fed a standard chow diet for 8 weeks, group Fru: rats were fed a high fructose diet (60% fructose) for 8 weeks, group FruA: rats were fed a high fructose diet and were co-infused with aliskiren (100 mg/kg/day), and group FruB: rats were treated as group Fru, but aliskiren was administered 4 weeks later. Systolic blood pressure (SBP), homeostasis model assessment-insulin resistance (HOMA-IR), and blood profiles were measured. Results: By the end of week 4 and 8 of a high fructose diet, SBP had increased significantly from 111 ±5 to 142 ±4 and 139 ±5 mmHg (p <0.05), respectively. A high fructose diet significantly increased HOMA-IR from baseline (6.15 ±1.59) to 21.25 ±2.08 and 21.28 ±3.1 (p <0.05) at week 4 and 8, respectively, and significantly induced metabolic syndrome. Concurrent aliskiren treatment prevented the development of hypertension and metabolic syndrome in fructosefed rats. When fructose-induced hypertension was established, subsequent aliskiren treatment for 4 weeks reversed the elevated SBP and ameliorated metabolic syndrome. There were no significant differences in food, water intake, urine flow or body weight gain among groups. Conclusions: Aliskiren not only prevents but also ameliorates metabolic syndrome in fructose-fed rats.

KW - Aliskiren

KW - Direct renin inhibitor

KW - Fructose

KW - Hypertension

KW - Metabolic syndrome

UR - http://www.scopus.com/inward/record.url?scp=81555210904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81555210904&partnerID=8YFLogxK

U2 - 10.5114/aoms.2011.25566

DO - 10.5114/aoms.2011.25566

M3 - Article

VL - 7

SP - 882

EP - 888

JO - Archives of Medical Science

JF - Archives of Medical Science

SN - 1734-1922

IS - 5

ER -